Coronavirus infection
Drug research and approvals for coronavirus infection: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 279 studies of coronavirus infection are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 279
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
- Improving Vaccine Efficacy for People With Helminth Infection: CORBEVAX in EthiopiaNCT07948395 · Phase 2 / Phase 3 · University of Aarhus · starts Oct 10, 2026
- Exploring the Extended Efficacy and Initial Use of RUCONEST® in Managing Neurological Symptoms Linked to Infectious…NCT07932002 · Phase 4 · IMMUNOe Research Centers · starts Nov 5, 2025
- CEDRN Pandemic Preparedness RegistryNCT07933861 · Not reported · University of British Columbia · starts Sep 1, 2026
- Study of a Combination SARS-CoV-2 Recombinant Spike and High-Dose Inactivated Influenza Vaccine With Matrix-M Adjuvant…NCT07890454 · Phase 3 · Sanofi · starts Oct 28, 2026
- Whole-body Cryotherapy in Those With Chronic Fatigue: A Feasibility StudyNCT07874217 · Not applicable · Oxford Brookes University · starts Oct 5, 2026
- A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing FormulationsNCT07863635 · Phase 4 · ModernaTX, Inc. · starts Oct 9, 2026
- Clinical and Therapeutic Outcomes by Molecular Subtype in Breast CancerNCT07856225 · Not reported · Fundación Santa Fe de Bogota · starts Dec 1, 2025
- A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years…NCT07808697 · Phase 2 · ModernaTX, Inc. · starts Sep 4, 2026
- Long-Term Study of COVID-19 Infection and Long COVIDNCT07781501 · Not reported · University of North Carolina, Chapel Hill · starts Nov 20, 2026
How its trials ended
871 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 221 whose ending is known, 21% met their primary endpoint, 18% missed it and 61% stopped early.
- Completed, result not reported34840%
- Status unknown22526%
- Stopped: other or unclear809%
- Ongoing779%
- Met its primary endpoint465%
- Missed its primary endpoint405%
- Stopped: enrollment or feasibility314%
- Stopped: sponsor or business decision101%
- Stopped: lack of efficacy91%
- Stopped: safety3<1%
- Stopped: funding2<1%
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA